Skip to content
MedsAcross

Medicine

Lincomycin 3000 mg/10 mL injection

Lincomycin · Intramuscular, intravenous
Available on requestPrescription onlyUS FDAGeneric name

Lincomycin 3000 mg/10 mL injection is a generic prescription medicine for intramuscular, intravenous use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Lincomycin
Brand
Sold under the generic name
Strength
3000 mg/10 mL
Dosage form
Injection
Route
Intramuscular, intravenous
Packs
1 vial of 10 mL, 10 vials of 10 mL and 3 more
Manufacturers
Micro LabsIndiaSlate Run PharmaceuticalsArmas PharmaceuticalsPAI Pharma
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J01FF02 Lincomycin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 February 2022
Identifiers
RxCUI 239212DailyMed set ID 23f9608c-3126-35db-e063-6294a90af054, 7efe038a-8d67-4151-864a-b4863b46643e, 20c0e8af-a78f-47f8-ace4-06b80def7003 +1NDC 0121-1035, 70436-035, 42571-374 +1Application ANDA212770, ANDA216662, ANDA215082

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 vial in 1 carton / 10 mL in 1 vial42571-374-88Micro LabsIndia1 February 2022
10 vial in 1 carton / 10 mL in 1 vial42571-374-89Micro LabsIndia1 August 2026
10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose72485-115-10Armas Pharmaceuticals5 May 2023
10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose0121-1035-55PAI Pharma7 October 2024
1 vial in 1 carton / 10 mL in 1 vial70436-035-80Slate Run Pharmaceuticals23 February 2023
10 vial in 1 carton / 10 mL in 1 vial70436-035-82Slate Run Pharmaceuticals23 February 2023
1 vial in 1 carton / 10 mL in 1 vial68083-479-01—26 September 2022
10 vial in 1 carton / 10 mL in 1 vial25021-193-10—15 April 2023
10 mL in 1 vial39822-0353-6—5 July 2015
1 vial in 1 bag / 10 mL in 1 vial0404-9901-10—12 January 2022

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 29 December 1964Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Lincomycin 3000 mg/10 mL injection.

Compare all 2

Other strengths and forms of Lincomycin

Clinical summary

Lincomycin is a prescription medicine indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci, among other approved uses. It is available as injection for intramuscular, intravenous and subconjunctival use. MedsAcross supplies Lincomycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Lincomycin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Lincomycin 3000 mg/10 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.